Bolt Biotherapeutics, Inc. (BOLT) stock
BOLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/305% above fair value
$5.65−0.15 (-2.59%)
Close on Nov 17, 2026Market cap $10.88MP/E –Yield –
Bolt Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Bolt Biotherapeutics's market cap was $12.06M on Nov 11, 2026, against $9.73M a year earlier. Over the last 5 years it ranged from $7.09M to $182.52M, with a median of $28.85M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $12.06M | +14.9% |
| 2025 | Dec 31, 2025 | $10.50M | -48.8% |
| 2024 | Dec 31, 2024 | $20.48M | -51.8% |
| 2023 | Dec 29, 2023 | $42.52M | -13.1% |
| 2022 | Dec 30, 2022 | $48.96M | -73.2% |
| 2021 | Dec 31, 2021 | $182.52M | – |
See a number that looks wrong?